Case Study: Postoperative Treatment of Prostate Cancer

Video

For High-Definition, Click

Moderator, Raoul S. Concepcion, MD, presents a case study of a 62 year-old Caucasian patient with a PSA of 6 ng/mL and a strong family history of prostate cancer. Following an evaluation, the patient decided to undergo a 12-core biopsy, which found that 4 of the 12 cores were 40% to 60% positive for Gleason 4+3 disease.

As a result, the patient elected to undergo robotically assisted radical retropubic prostatectomy. According to the final pathology report, Concepcion explains, the Gleason score was 4+3 and the lesion was pathologic stage T3a with a questionable apical surgical margins. Overall, the patient was node negative without evidence of metastatic disease. At 3 months following surgery, the PSA nadir was determined to be 0.2 ng/mL.

Several of the postoperative indicators seem to note the presence of residual disease, particularly the lack of an undetectable PSA level, believes Leonard G. Gomella, MD. As a result, a nomogram should be utilized to gauge the risk of recurrence. If the risk is greater than 50%, adjuvant radiation therapy should be administered.

Related Videos
Timothy Yap, MBBS, PhD, FRCP
Kara N. Maxwell, MD, PhD
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Rohan Garje, MD
Jeffrey P. Townsend, PhD
Rohan Garje, MD
Josep Maria Piulats Rodriguez, MD, PhD
Angela Jia, MD, PhD, of University Hospitals
Rohan Garje, MD, chief, Genitourinary Medical Oncology, Baptist Health Miami Cancer Institute
Kara N. Maxwell, MD, PhD